Background: The success of clinical transplantation has led to a large disc
repancy between donor organ availability and demand; considerable pressure
exists to develop an alternative source of organs. The use of animal organs
for donation is a possible solution that is not yet clinically applicable.
Methods and results: A literature review was performed based on a Medline s
earch to find articles on xenotransplantation. Keywords included hyperacute
, acute vascular, xenograft rejection combined with concordant and discorda
nt. Additional references cited in these articles from journals not include
d in Medline were obtained from the British Library. Limited information on
unpublished, preliminary work has been included from sources known to the
authors, based on their research work in the field. One hundred and forty-s
ix references and four personal communications have been included in this r
eview article.
Conclusion: A greater understanding of the pathogenesis of xenograft reject
ion is developing rapidly. Strategies to abrogate hyperacute rejection have
proved successful, but control of antibody-driven acute vascular rejection
has not yet been achieved. The safety and viability of xenotransplantation
as a therapeutic modality are still unproven.